• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二次接种新冠疫苗五个月后新冠病毒抗刺突IgG抗体的评估。

Evaluation of Covid-19 anti-spike IgG antibody five months after the second Covid-19 vaccination.

作者信息

Rafie Reyhaneh Alipoor, Azimi Leila, Armin Shahnaz, Aghamohammadi Amirali, Karimi Abdollah, Fallah Fatemeh, Khodaei Hannan, Mansour Ghanaie Roxana, Alebouyeh Masoud

机构信息

Department of Infectious Diseases, Shahid Beheshti University of Medical sciences, Tehran, Iran.

Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

GMS Hyg Infect Control. 2023 Sep 7;18:Doc20. doi: 10.3205/dgkh000446. eCollection 2023.

DOI:10.3205/dgkh000446
PMID:37829253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10566013/
Abstract

BACKGROUND

Studies in different communities have shown significant differences in IgG antibody titers in the time period after the first and second doses of the vaccines. This study aimed to serologically evaluate the IgG anti-spike antibody titer five months after injection of the second COVID-19 vaccine in healthcare workers.

MATERIALS AND METHOD

This study was performed in healthcare personnel for whom five months had passed since their second anti-Covid-19 vaccination. The level of IgG antibody against SARS-CoV-2 spike protein was measured by ELISA. Healthcare workers in Mofid Children's hospital received three brands of vaccines: Sputnik V, Sinopharm, and AstraZeneca.

RESULTS

The mean titer of anti-spike IgG was 4.3±2.29 units. The percentage of positive cases of the antibody was estimated to be 96.4%. The titer of anti-spike IgG antibody was dependent on both the occupational area and a positive history of Covid-19 disease.

CONCLUSION

About 96.4% of the staff vaccinated against Covid-19 had a high titer of anti-spike IgG antibody even five months after inoculation of the second dose. The field of occupational can affect the level of antibody present.

摘要

背景

不同社区的研究表明,在接种第一剂和第二剂疫苗后的时间段内,IgG抗体滴度存在显著差异。本研究旨在对医护人员接种第二剂新冠疫苗五个月后的IgG抗刺突抗体滴度进行血清学评估。

材料与方法

本研究针对自第二次接种新冠疫苗已过去五个月的医护人员开展。采用酶联免疫吸附测定法(ELISA)检测针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的IgG抗体水平。莫菲德儿童医院的医护人员接种了三种品牌的疫苗:卫星五号、国药集团疫苗和阿斯利康疫苗。

结果

抗刺突IgG的平均滴度为4.3±2.29个单位。抗体阳性病例的百分比估计为96.4%。抗刺突IgG抗体的滴度既取决于职业领域,也取决于新冠疾病的阳性病史。

结论

即使在接种第二剂疫苗五个月后,约96.4%接种新冠疫苗的工作人员仍具有高滴度的抗刺突IgG抗体。职业领域会影响抗体水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/10566013/f6815f401c6f/HIC-18-20-t-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/10566013/3fc3b389b266/HIC-18-20-t-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/10566013/f6815f401c6f/HIC-18-20-t-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/10566013/3fc3b389b266/HIC-18-20-t-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/10566013/f6815f401c6f/HIC-18-20-t-002.jpg

相似文献

1
Evaluation of Covid-19 anti-spike IgG antibody five months after the second Covid-19 vaccination.第二次接种新冠疫苗五个月后新冠病毒抗刺突IgG抗体的评估。
GMS Hyg Infect Control. 2023 Sep 7;18:Doc20. doi: 10.3205/dgkh000446. eCollection 2023.
2
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.不同类型疫苗的抗 SARS-CoV-2 RBD IgG 抗体反应的有效性和持续时间比较:对疫苗策略的影响。
Vaccine. 2022 May 3;40(20):2841-2847. doi: 10.1016/j.vaccine.2022.03.069. Epub 2022 Apr 1.
3
Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran.评估伊朗某单一中心接种疫苗的医护人员对不同 COVID-19 疫苗的反应。
J Med Virol. 2022 Dec;94(12):5669-5677. doi: 10.1002/jmv.28029. Epub 2022 Aug 4.
4
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
5
Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.韩国医护人员接种第二剂 BNT162b2 mRNA 疫苗 6 个月后仍保持对 SARS-CoV-2 的抗体应答。
Front Immunol. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306. eCollection 2022.
6
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
7
Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers.医护人员接种第二剂 BNT162b2 新冠疫苗后抗刺突 IgG 抗体水平的动态变化。
J Infect Chemother. 2022 Jun;28(6):802-805. doi: 10.1016/j.jiac.2022.02.024. Epub 2022 Mar 8.
8
Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a multicentre cross-sectional study on inactivated, mRNA and vector-based vaccines.评估医护人员 COVID-19 疫苗接种后早期和晚期的抗体反应:一项关于灭活疫苗、mRNA 疫苗和载体疫苗的多中心横断面研究。
Epidemiol Infect. 2023 Jan 5;151:e12. doi: 10.1017/S0950268822001984.
9
Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq.伊拉克埃尔比勒市 COVID-19 患者接种辉瑞、阿斯利康和中国国药疫苗产生的抗体水平比较。
Cell Mol Biol (Noisy-le-grand). 2023 Mar 31;69(3):103-112. doi: 10.14715/cmb/2023.69.3.14.
10
Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.影响医护人员抗 SARS-CoV-2 刺突 IgG 抗体效价的因素:一项横断面研究。
J Med Virol. 2023 Jan;95(1):e28300. doi: 10.1002/jmv.28300. Epub 2022 Nov 18.

本文引用的文献

1
A Quantitative ELISA to Detect Anti-SARS-CoV-2 Spike IgG Antibodies in Infected Patients and Vaccinated Individuals.一种用于检测感染患者和接种疫苗个体中抗SARS-CoV-2刺突IgG抗体的定量酶联免疫吸附测定法。
Microorganisms. 2022 Sep 9;10(9):1812. doi: 10.3390/microorganisms10091812.
2
Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B.1.1.7) Variant in Men's Correctional Facility, United States.新冠病毒 Alpha(B.1.1.7)变异株在美国男子惩教所爆发期间的疫苗效力。
Emerg Infect Dis. 2022 Jul;28(7):1313-1320. doi: 10.3201/eid2807.220091.
3
Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection.
新型冠状病毒感染后急性后遗症中的炎症、免疫和抗原持续存在。 新型冠状病毒感染后急性后遗症中的免疫与炎症。
Curr Opin Immunol. 2022 Aug;77:102228. doi: 10.1016/j.coi.2022.102228. Epub 2022 May 24.
4
COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.疫苗实施期间的 COVID-19 退出策略:在社交距离和群体免疫之间取得平衡。
Arch Virol. 2022 Sep;167(9):1773-1783. doi: 10.1007/s00705-022-05495-7. Epub 2022 Jun 20.
5
Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus.塞浦路斯人群中针对 SARS-CoV-2 的免疫球蛋白 G 抗体的血清阳性率。
PLoS One. 2022 Jun 13;17(6):e0269885. doi: 10.1371/journal.pone.0269885. eCollection 2022.
6
Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.接种 BNT162b2 疫苗后医护人员抗严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白抗体效价和中和活性的相关因素。
PLoS One. 2022 Jun 10;17(6):e0269917. doi: 10.1371/journal.pone.0269917. eCollection 2022.
7
Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection.有和没有既往 SARS-CoV-2 感染人群对 COVID-19 疫苗接种的免疫反应。
Ir J Med Sci. 2023 Apr;192(2):731-739. doi: 10.1007/s11845-022-03044-4. Epub 2022 Jun 9.
8
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies.SARS-CoV-2 宿主关闭会影响先天 NK 细胞的功能,但通过非刺突抗体强烈激活抗体依赖性 NK 活性。
Elife. 2022 May 19;11:e74489. doi: 10.7554/eLife.74489.
9
Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine.接种BNT162b2 mRNA疫苗九个月后医护人员循环抗SARS-CoV-2抗体滴度降低与COVID-19感染风险
Vaccines (Basel). 2022 Jan 18;10(2):141. doi: 10.3390/vaccines10020141.
10
Population antibody responses following COVID-19 vaccination in 212,102 individuals.212102 例个体接种 COVID-19 疫苗后的人群抗体反应。
Nat Commun. 2022 Feb 16;13(1):907. doi: 10.1038/s41467-022-28527-x.